Imipem, a very broad spectrum antimicrobial drug was given t o 40 children ranging in age from 3 months t o 13 years (rredian 2 years). Children younger than 3 years received 100 rrg/kg/day and c h i l d r e n o l d e r than 3 y e a r s received 60 mg/kg/day. 29 organisms were i s o l a t e d from 26 p a t i e n t s .
1 L S G d J r I S , e n t e r i t i d e s . 6 p a t i e n t s were bacteremic ( 5 H. influenza, 1 S. pneumonia). P a t i e n t s were t r e a t e d f o r 2 t o 14 days (mean 6 days). A l l responded favorably w i t h s t e r i l i z a t i o n of the infected site, defervescence and improvement in t h e l o c a l findings. A l l the organisms were s u s c e p t i b l e t o imipenem, and none developed resistance. There were no superinfections. 40 p a t i e n t s were analyzed f o r tolerance and safety. Imipenem was well t o l e r a t e d and t h e r e were no s i g n i f i c a n t s i d e e f f e c t s . Transient s i d e e f f e c t s noted were: i r r i t a t i o n of i v site (3), d i a r r h e a (2) , SGOr e l e v a t i o n (2) , leukopenia (1).
Rapid d e t e c t i o n o f h m c y t o~a l o v i r u s . G Al-7 1052 p e r t , , plotkin, u n i v e r s i t y of Pennsylvania.
We detected t h e presence of CMV i n u r i n e using MRC-5 c e l l s inoculated by l& speed c e n t r i f u g a t i o n and s t a i n e d in a bridged i n d i r e c t a v i d i n b i o t i n fluorescent s t a i n using E13, a c o n e r c i a l l y a v a i l a b l e m n c c l o n a l antiOody t h a t d e t e c t s an inmediate e a r l y nuclear antigen. Of 88 specimens, 37 were p o s i t i v e f o r CMV e i t h e r by c u l t u r i n g (31 specimens) o r by the rapid d e t e c t i o n method (36 specimens) . C w r i s o n of t h e methods is presented in t h e t a b l e .
Fg i w e
Eluorescence Necrative With Without With Without Centrifugation Centrifugation c u l t u r e + 30 c u l t u r e -6 l9 1 -56 97% of t h e c u l t u r e p o s i t i v e specimens were detected by t h e rapid d e t e c t i o n methcd within 24 hours. The mean length of incubation t o appearance of CPE was 1 8 days. 1 5 specimens had a titer of 1 x 101 pfu/ml o r less; 3 had 1 102 fu/ml; 2 had I 103 pfu/ml, 1 had 1 104 pfu/r.~ and 2 had > 18 p f u h~.
The 6 " f a l s e positive" specimens belong t o 5 p a t i e n t s known t o be s e r o p o s i t i v e f o r CMV. 2 of the p a t i e n t s had a u r i n e specimen p o s i t i v e f o r CMV on c u l t u r e 2 weeks later, and 1 had a t h r o a t wash p o s i t i v e i n c u l t u r e f o r CMV at t h e sane day t h a t t h e u r i n e was t e s t e d . Our method is sinple, rapid, and is as s e n s i t i v e as a t i s s u e c u l t u r e f o r determination of CMV.
GESTATIONAL VARICELLA ZOSTER VIRUS (VZV) INFECTION IN GUINEA PIGS. Sherman J. Alter and
Myers, University of Cincinnati, Childrents Hosp. Med. Ctr., Department of Pediatrics, Cincinnati.
Although uncommon, gestational varicella has potential for severe consequences.
Fetal wastage and congenital anomalies have been associated with early gestation maternal infection while progressive neonatal disease has been associated with perinatal infection.
To study congenital infection, strain 2 guinea pigs, known to be successful breeders for 5 3 pregnancies, were either infected with 4.2 log pfu VZV or sham inoculated a t 23-57 days gestation. Five i n f g t e d pregnancies resulted in the spontaneous death of all offspring; one with maternal death, one with in utero resorption, one with a stillborn litter, and two litters with death of all offspring between 4-15 days of age. Three additional pregnancies progressed to full-term delivery. Of 26 total offspring, I1 were stillborn, three died in utero, and six died in the neonatal period; three had congenital cataracts.
Eight of 29 pups born t o sham inoculated animals were stillborn. nn additional animal, infected a t five weeks gestation, was sacrificed six days after inoculation: VZV was detected by explant co-cultivation or dot blot DNA hybridization from multiple maternal and fetal tissues.
Gestational VZV infection in the guinea pig causes fetal wastage, altered intrauterine development, and increased perinatal mortality. PA. 19104 CNS is being reported with greater frequency in neonatal disease. A case-controlled study to determine the incidence and risk factors associated with CNS bacteremia, was conducted from 1/82 -9184 a t the Hosp. of the Univ. of PA. A total of 57 nosocomial bacteremias were detected with 42 (74%) due to CNS, an incidence of 5.4/1000 live births. Mean age of onset was 26 days (range, 7-100 days). All infants with CNS had signs and symptoms of sepsis with recurrent bradycardia and pallor or cyanosis. Recurrent apnea, temperature instability, and feeding intolerance occurred in 7 70% of the infants. The most frequent hematologic abnormality was an immatureltotal neutrophil count 7 0.2 (45%). A comparison of CNS to randomly selected Controls (numbers are mean 2 SD; *P= 4 0.01, **P= < 0.001) revealed: This study indicates that low birth weight infants with chronic lung disease requiring multiple supportive measures are a t highest risk for CNS bacteremia.
PROTEIN-OLIGOSACCHARIDE CONJUGATE VACCINE PRIMES IN-FANTS FOR A MATURE ANTIBODY (Ab) RESPONSE TO THE CAP-' SULAR POLYSACCWIDE (PRP) OF HAEMOPHILUS INFLUENZA8
TYPE B (HIB). Porter W. Anderson, Michael E. Pichichero (Spon.by R. I n s e l ) . Univ Rochester, Dept Peds, Rochester, New York.
Ab t o PRP a r e p r o t e c t i v e against systemic infections by Hib, but i n f a n t s under 18 mo usually have an inadequate Ab response t o PRP vaccine. To circumvent t h i s unresponsiveness, we conjugated oligosaccharides of PRP t o a p r o t e i n c a r r i e r , CRM197, anont o x i c version of diphtheria toxin. Infants were i n j e c t e d with t h e conjugate a t ages 2, 4, and 6 mo. A t age 9 mo t h e geometric mean t i t e r (GMT) of anti-PRP Ab i n a group of 5 such i n f a n t s was 2.0 ug/ml; the response included IgG Ab. In an unvaccinated cont r o l group of 13 i n f a n t s t h e GMT was 0.015 ug/ml, with no IgG included. Both groups were then vaccinated with PRP vaccine, and the anti-PRP Ab was measured 1 mo l a t e r . In t h e control group, 3/13 i n f a n t s had a r i s e , and t h e GMT rose t o 0.024 vg/ml. In t h e group primed with conjugate, 4/5 had a r i s e , and t h e GMT rose t o 7.2 pg/ml. Thus t h e conjugate i s able not only t o r a i s e t h e Ab t o high l e v e l s , but a l s o t o prime f o r an enhanced response t o t h e polymer. I t seems l i k e l y t h a t such a response would occur a l s o when t h e i n f a n t encounters Hib. Further, boosting with PRP a f t e r priming with conjugate may maintain t h e Ab a t an elevated level. A combination v a r i c e l l a ,~m a s l e s , -, and rubella vaccine was t e s t e d i n 17 healthy children aged 15-18 m n t h s . The sercconversion r a t e s were 100% f o r v a r i c e l l a (FAMA), 100% f o r measles (Micro HI), 93.7% f o r munps (EIA) and 100% f o r rubella (FWL) . I n addition, 3/4 vaccinees who were low titer seroposit i v e on day 0 f o r a n t i -v a r i c e l l a antibody had a 2 4 f o l d increase i n titer. Rashes occurred i n 7/17, 5 m r b i l l i f o r m and 2 had rashes s i m i l a r t o v a r i c e l l a vaccine rashes as previously described. None had vesicular eruption. Three c h i l d r e n had temperature above 38.3OC, 2 w i t h m r b i l l i f o r m rashes, 1 with v a r i c e l l a vaccine l i k e rash.
I n another study, t h e v a r i c e l l a vaccine was administered in a double blind placebo controlled t r i a l of p o s t exposure prophyl a x i s . W i t h i n 5 days of a s i b l i n g household exposure, 1 3 c h i l d r e n received vaccine and 13 children received placebo.
Twelve of 1 3 placebo r e c i p i e n t s developed v a r i c e l l a (60-600 l e s i o n s ) while 4 o f 13 vaccinees developed mild v a r i c e l l a (2-50 l e s i o n s ) . Three of 4 vaccinees who developed mild v a r i c e l l a were irranunized > 3 days a f t e r exposure. The p r o t e c t i v e e f f i c a c y was 67%, p < 0.I03; protection p l u s modification e f f i c a c y was 100%, p , 0.80fl003. These d a t a i n d i c a t e that the v a r i c e l l a vaccine is inmunogenic i n combination with the MMR and is successful when given separ a t e l y f o r p o s t exposure prophylaxis.
